S Matsuoka Selected Research

Myositis (Idiopathic Inflammatory Myopathies)

1/2007

Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Matsuoka Research Topics

Disease

2	Neoplasms (Cancer) 01/2017 - 01/2010
2	Dyspnea (Shortness of Breath) 01/2007 - 07/2000
2	Hemorrhage 01/2005 - 07/2001
2	Pneumonia (Pneumonitis) 01/2005 - 05/2000
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2019
1	Hematoma 01/2018
1	Ulcer 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2017
1	Leiomyoma (Uterine Fibroids) 01/2017
1	Bites and Stings (Sting) 01/2015
1	Glomerulonephritis 07/2014
1	Systemic Vasculitis 07/2014
1	Serous Cystadenocarcinoma 01/2010
1	Endometrial Neoplasms (Endometrial Cancer) 01/2010
1	Hemoperitoneum 01/2009
1	Cornual Pregnancy 01/2009
1	Infections 01/2009
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2007
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2007
1	Dermatomyositis (Dermatopolymyositis) 01/2007
1	Acute Lung Injury 01/2005
1	Pulmonary Sarcoidosis 12/2001
1	Lung Neoplasms (Lung Cancer) 07/2001
1	Hemorrhagic Shock 07/2001
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2001
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 02/2001
1	Complete atrioventricular septal defect 10/2000
1	Ventricular Heart Septal Defects (Ventricular Septal Defect) 10/2000
1	Hypertension (High Blood Pressure) 10/2000
1	Vascular Diseases (Vascular Disease) 10/2000
1	Multiple System Atrophy 07/2000
1	Autoimmune Hepatitis 05/2000
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 05/2000
1	Pancytopenia 05/2000
1	Retinitis 04/2000
1	Gastroenteritis 04/2000
1	Dementia (Dementias) 02/2000
1	AIDS Dementia Complex 02/2000
1	Opportunistic Infections (Opportunistic Infection) 02/2000

Drug/Important Bio-Agent (IBA)

2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2019 - 01/2007
2	Peroxidase (Myeloperoxidase)IBA 07/2014 - 01/2005
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2019
1	Busulfan (Busulfex)FDA Link 04/2019
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2019
1	fludarabineIBA 04/2019
1	AntigensIBA 01/2018
1	AutoantibodiesIBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2017
1	Gemcitabine FDA Link 01/2017
1	Antivenins (Antivenoms)IBA 01/2015
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2014
1	MesothelinIBA 01/2010
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2010
1	AntibodiesIBA 01/2007
1	Oxygen (Dioxygen)IBA 01/2007
1	Tetradecanoylphorbol AcetateIBA 01/2005
1	SodiumIBA 01/2005
1	Proteins (Proteins, Gene)FDA Link 01/2005
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2005
1	EnzymesIBA 01/2005
1	sivelestatIBA 01/2005
1	Secretory Proteinase Inhibitory ProteinsIBA 01/2005
1	gallium citrateIBA 12/2001
1	Phosphotransferases (Kinase)IBA 07/2001
1	technetium Tc 99m DTPA-galactosyl-human serum albuminIBA 02/2001
1	technetium Tc 99m pyrrolidino-methyltetracyclineIBA 02/2001
1	Carbon DioxideIBA 10/2000
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 07/2000
1	Indium-111IBA 05/2000
1	ChloridesIBA 05/2000
1	RNA (Ribonucleic Acid)IBA 02/2000
1	NucleosidesIBA 02/2000
1	Reverse Transcriptase InhibitorsIBA 02/2000
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2000

Therapy/Procedure

4	Therapeutics 01/2007 - 02/2000
2	Laparotomy 01/2017 - 01/2009
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2019
1	Intravenous Administration 04/2019
1	Oral Administration 04/2019
1	Epidural Analgesia 01/2018
1	Adjuvant Chemotherapy 01/2017
1	Uterine Myomectomy 01/2017
1	Hysterectomy 01/2009
1	Catheters 07/2001
1	Resuscitation 07/2001
1	Autologous Transplantation 02/2001
1	Flowmeters 10/2000
1	Tracheostomy 07/2000
1	Aftercare (After-Treatment) 05/2000
1	Highly Active Antiretroviral Therapy (HAART) 02/2000